Game da-ciwon daji / jiyya / gwaji-gwaji / gwajin-kwayar cutar
Gwajin gwaji don Kula da Ciwon Canji
Gwaji 1-4 na 4
Nivolumab da Ipilimumab a Kula da Marasa lafiya da Ciwan Tumuwa
Wannan karatuttukan gwaji na lokaci na biyu nivolumab da ipilimumab wajen kula da marasa lafiya da ƙananan ƙwayoyi. Immunotherapy tare da kwayoyin cuta na monoclonal, irin su nivolumab da ipilimumab, na iya taimakawa tsarin garkuwar jiki ya kai hari kansar, kuma yana iya tsoma baki tare da ikon ƙwayoyin tumo don girma da yaɗuwa. Wannan gwajin ya sanya mahalarta don masu haɗin gwiwa masu zuwa bisa ga yanayin: 1. Cutar tumɓir na ƙoshin hanci, sinuses, nasopharynx: A) Ciwon ƙwayar ƙwayar ƙwayar ƙwayar cuta tare da nau'ikan ramin hanci, sinuses, da nasopharynx da trachea (ban da laryngeal, nasopharyngeal cancer [NPC] , da kwayar cutar kankara da ke kan mutum da wuya [SCCHN]) B) Adenocarcinoma da bambance-bambancen jijiyar hanci, sinuses, da nasopharynx (rufe zuwa taruwa 07/27/2018) 2. Cutar tumfafir na manyan gland na jijiyoyin jiki (rufe don taruwa 03 / 20/2018) 3. Nauyin gland na salivary na ciwan kai da wuya, lebe, esophagus, ciki, trachea da huhu, nono da sauran wurare (rufe don tarawa) 4. Carcinoma da ba a rarrabe a cikin hanji na hanji (GI) 5. Adenocarcinoma tare da bambance-bambancen ƙananan hanji (an rufe don tarawa) 05/10/2018) 6. Kwayar cututtukan ƙwayoyin ƙwayoyin ƙwayoyin cuta tare da nau'ikan GI tract (ƙananan hanji, hanji, dubura, ƙuƙwarar)) (an rufe shi zuwa ƙara 10/17/2018) 7. Fibromixoma da adenocarcinoma mai ƙananan mucinous (pseudomixoma peritonei) na appendix da ovary (an rufe su don tarawa 03/20/2018) 8. Rare pancreatic ciwan ciki har da acinar cell carcinoma, mucinous cystadenocarcinoma ko serous cystadenocarcinoma. Pancreatic adenocarcinoma bai cancanci 9. Intrahepatic cholangiocarcinoma (an rufe shi don tarawa 03/20/2018) 10. Extrahepatic cholangiocarcinoma da bile duct marurai (an rufe su don tarawa 03/20/2018) 11. Sarcomatoid carcinoma na huhu 12. Bronchoalveolar carcinoma lung. Wannan yanayin yanzu ana kiransa adenocarcinoma a cikin wuri, adenocarcinoma mai saurin lalacewa, adenocarcinoma mai yaduwa, ko adenocarcinoma mai rikitarwa 13. Rashin ƙwayar epithelial na ovary: A) Ciwon ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta ta B zuwa tara 03/30/2018) 14. Trophoblastic tumor: A) Choriocarcinoma (an rufe shi zuwa tarawa) 15. Ciwon ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar magungunan ƙwayar ƙwayar ƙwayar cuta a cikin ƙwayar cuta ta jiki a cikin kwayar cutar ta jiki: A) Choriocarcinoma (an rufe shi don tarawa) 15. Ciwon ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta ba tare da na koda ba, ƙashin ƙugu, ureter, ko mafitsara (an rufe shi don tarawa) 16. Kwayar ƙwayar ƙwayar Gwaji da cututtukan ƙwayoyin cuta masu yawa: A) Seminoma da cutar sankara ta maza B) Cutar non-seminomatous C) Teratoma tare da mummunan canji (rufe zuwa ƙara) 17.
Wuri: wurare 895
Kulawa mai aiki, Bleomycin, Carboplatin, Etoposide, ko Cisplatin a Kula da Yara da Balagaggun Magunguna tare da Ciwon ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta . Kulawa mai aiki na iya taimaka wa likitoci su lura da batutuwa da ƙananan ƙwayoyin ƙwayoyin ƙwayoyin cuta bayan an cire ƙwayar cutar. Magungunan da ake amfani da su a chemotherapy, kamar bleomycin, carboplatin, etoposide, da cisplatin, suna aiki ta hanyoyi daban-daban don dakatar da haɓakar ƙwayoyin tumo, ko dai ta hanyar kashe ƙwayoyin, ta hana su rarraba, ko ta hana su yaɗuwa. Wuri: Wurare 460
Inotuzumab Ozogamicin da Chemotherapy na Post-Induction don Kula da Marasa lafiya tare da Haɗari mai Girma B-ALL, Cutar Maɗaukakiyar Cutar Cutar sankarar bargo, da B-LLy
Wannan gwajin gwaji na lokaci na uku yana nazarin ko inotuzumab ozogamicin da aka kara zuwa chemotherapy bayan fitarwa don marasa lafiya tare da High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) yana inganta sakamako. Wannan gwaji kuma yana nazarin sakamakon marasa lafiya tare da cututtukan cututtukan ƙwayoyin cuta masu haɗari (MPAL), da B-lymphoblastic lymphoma (B-LLy) lokacin da aka bi da su tare da ALL far ba tare da inotuzumab ozogamicin ba. Inotuzumab ozogamicin wata cuta ce ta monoclonal, ana kiranta inotuzumab, wanda ke da alaƙa da wani nau'in maganin ƙwaƙwalwa wanda ake kira calicheamicin. Inotuzumab yana rataye da ƙwayoyin cutar kansa ta wata hanyar da aka nufa da bayar da calicheamicin don kashe su. Sauran magungunan da aka yi amfani da su a cikin maganin cutar sankara, kamar cyclophosphamide, cytarabine, dexamethasone, doxorubicin, daunorubicin, methotrexate, leucovorin, mercaptopurine, prednisone, thioguanine, vincristine, da pegaspargase suna aiki ta hanyoyi daban-daban don dakatar da ci gaban ƙwayoyin kansa, ko dai ta hanyar kashe ƙwayoyin, ta hana su rarraba, ko ta hana su yaɗuwa. Wannan gwajin zai kuma bincika sakamakon marasa lafiya tare da cututtukan cututtukan cututtukan ƙwayoyin cuta masu haɗari (MPAL) da kuma rarraba B lymphoblastic lymphoma (B-LLy) lokacin da aka bi da su tare da haɗari ALL ALL chemotherapy. Babban manufar wannan binciken shine fahimtar idan ƙara inotuzumab ozogamicin zuwa daidaitaccen kulawar cutar shan magani yana kiyaye ko inganta sakamako a cikin High Risk B-cell Acute Lymphoblastic Leukemia (HR B-ALL). Sashi na farko na binciken ya hada da matakai biyu na farko na farfadowa: uunƙwasawa da Haɗawa. Wannan bangare zai tattara bayanai game da cutar sankarar bargo, da kuma tasirin magani na farko, domin kasafta marasa lafiya cikin kungiyoyin kula da bayan an karfafa su. A bangare na biyu na wannan binciken, marasa lafiya za su karbi ragowar abubuwan da ke tattare da maganin cutar sankara (kulawar wucin gadi na I, jinkirin fadadawa, rikon kwarya II, kiyayewa), tare da wasu marasa lafiya da bazuwar karbar inotuzumab. Sauran manufofin wannan binciken sun hada da binciko ko magance maza da mata tare da tsawon lokacin cutar shan magani suna kula da sakamako ga mazan da aka ba su kulawa a baya don karin shekara idan aka kwatanta da 'yan mata, da kuma kimanta hanyoyin da suka fi dacewa don taimaka wa marassa lafiya biyewa Tsarin kemotherapy. A ƙarshe, wannan binciken zai zama na farko don bin diddigin sakamakon batutuwa tare da yada kwayar cutar B-cell Lymphoblastic Leukemia (B LLy) ko Mixed Phenotype Acute Leukemia (MPAL) lokacin da aka bi da su da B-ALL chemotherapy. marasa lafiya za su karɓi ragowar abubuwan da ke tattare da cutar sankarar magani (kulawa ta wucin gadi I, jinkirin ƙarfafawa, kiyayewar wucin gadi II, kiyayewa), tare da wasu marasa lafiya da aka bazu don karɓar inotuzumab. Sauran manufofin wannan binciken sun hada da binciko ko magance maza da mata tare da tsawon lokacin cutar shan magani suna kula da sakamako ga mazan da aka ba su kulawa a baya don karin shekara idan aka kwatanta da 'yan mata, da kuma kimanta hanyoyin da suka fi dacewa don taimaka wa marassa lafiya biyewa Tsarin kemotherapy. A ƙarshe, wannan binciken zai zama na farko don bin diddigin sakamakon batutuwa tare da yada kwayar cutar B-cell Lymphoblastic Leukemia (B LLy) ko Mixed Phenotype Acute Leukemia (MPAL) lokacin da aka bi da su da B-ALL chemotherapy. marasa lafiya za su karɓi ragowar abubuwan da ke tattare da cutar sankarar magani (kulawa ta wucin gadi I, jinkirin ƙarfafawa, kiyayewar wucin gadi II, kiyayewa), tare da wasu marasa lafiya da aka bazu don karɓar inotuzumab. Sauran manufofin wannan binciken sun hada da binciko ko magance maza da mata tare da tsawon lokacin cutar shan magani suna kula da sakamako ga mazan da aka ba su kulawa a baya don karin shekara idan aka kwatanta da 'yan mata, da kuma kimanta hanyoyin da suka fi dacewa don taimaka wa marassa lafiya biyewa Tsarin kemotherapy. A ƙarshe, wannan binciken zai zama na farko don bin diddigin sakamakon batutuwa tare da yada kwayar cutar B-cell Lymphoblastic Leukemia (B LLy) ko Mixed Phenotype Acute Leukemia (MPAL) lokacin da aka bi da su da B-ALL chemotherapy. Sauran manufofin wannan binciken sun hada da binciko ko magance maza da mata tare da tsawon lokacin cutar shan magani suna kula da sakamako ga mazan da aka ba su kulawa a baya don karin shekara idan aka kwatanta da 'yan mata, da kuma kimanta hanyoyin da suka fi dacewa don taimaka wa marassa lafiya biyewa Tsarin kemotherapy. A ƙarshe, wannan binciken zai zama na farko don bin diddigin sakamakon batutuwa tare da yada kwayar cutar B-cell Lymphoblastic Leukemia (B LLy) ko Mixed Phenotype Acute Leukemia (MPAL) lokacin da aka bi da su da B-ALL chemotherapy. Sauran manufofin wannan binciken sun hada da binciko ko magance maza da mata tare da tsawon lokacin cutar shan magani suna kula da sakamako ga mazan da aka ba su kulawa a baya don karin shekara idan aka kwatanta da 'yan mata, da kuma kimanta hanyoyin da suka fi dacewa don taimaka wa marassa lafiya biyewa Tsarin kemotherapy. A ƙarshe, wannan binciken zai zama na farko don bin diddigin sakamakon batutuwa tare da yada kwayar cutar B-cell Lymphoblastic Leukemia (B LLy) ko Mixed Phenotype Acute Leukemia (MPAL) lokacin da aka bi da su da B-ALL chemotherapy.
Wuri: Wurare 189
Celeara sauri ko Tsarin BEP Chemotherapy a Kula da Marasa lafiya tare da Matsakaici ko orananan -unƙarar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta
Wannan gwajin lokaci na bazuwar yayi nazarin yadda ingantaccen jadawalin bleomycin sulfate, etoposide phosphate, da cisplatin (BEP) chemotherapy ke aiki idan aka kwatanta da jadawalin jadawalin BEP chemotherapy wajen kula da marasa lafiya tare da matsakaici ko ƙwayoyin cuta ƙwayoyin cuta waɗanda suka bazu zuwa wasu wurare a cikin jiki (metastatic). Magungunan da ake amfani da su a cikin cutar sankara, kamar su bleomycin sulfate, etoposide phosphate, da cisplatin, suna aiki ta hanyoyi daban-daban don dakatar da haɓakar ƙwayoyin tumo, ko dai ta hanyar kashe ƙwayoyin, ta hana su rarraba, ko ta hana su yaɗuwa. Bada BEP chemotherapy akan saurin, ko "hanzarta" jadawalin na iya aiki mafi kyau tare da ƙananan sakamako masu illa a kula da marasa lafiya tare da matsakaici ko ƙarancin haɗarin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta idan aka kwatanta da daidaitaccen tsarin.
Wuri: Wurare 139
Enable sharhi mai-sabuntawa na atomatik